These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2011676)

  • 1. [Current salazosulfapyridine derivatives in the treatment of Crohn's disease].
    Belaiche J; Delwaide J; Louis E; Gast P
    Rev Med Liege; 1991 Jan; 46(1):16-22. PubMed ID: 2011676
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Crohn's disease with 5-ASA.
    Katz J
    Am J Gastroenterol; 1993 Sep; 88(9):1315-7. PubMed ID: 8362823
    [No Abstract]   [Full Text] [Related]  

  • 3. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
    Feurle GE; Helmstädter V
    Dtsch Med Wochenschr; 1986 May; 111(18):721-2. PubMed ID: 2870908
    [No Abstract]   [Full Text] [Related]  

  • 4. [Successful acute treatment of chronic inflammatory intestinal diseases with oral 5-aminosalicylic acid].
    Maier K; Frühmorgen P; Bode JC; Heller T; von Gaisberg U; Klotz U
    Dtsch Med Wochenschr; 1985 Mar; 110(10):363-8. PubMed ID: 2857633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute pancreatitis in Crohn's disease due to 5-ASA therapy.
    Radke M; Bartolomaeus G; Müller M; Richter I
    J Pediatr Gastroenterol Nutr; 1993 Apr; 16(3):337-9. PubMed ID: 8492268
    [No Abstract]   [Full Text] [Related]  

  • 6. Pericardial effusion during treatment with 5-aminosalicylic acid in a patient with Crohn's disease.
    Jenss H; Becker EW; Weber P
    Am J Gastroenterol; 1990 Mar; 85(3):332-3. PubMed ID: 2309693
    [No Abstract]   [Full Text] [Related]  

  • 7. Second trial of mesalamine therapy in the treatment of active Crohn's disease.
    Singleton J
    Gastroenterology; 1994 Aug; 107(2):632-3. PubMed ID: 8039647
    [No Abstract]   [Full Text] [Related]  

  • 8. Maintaining remission of Crohn's disease.
    Novak E
    CMAJ; 1988 Jul; 139(1):14. PubMed ID: 3383034
    [No Abstract]   [Full Text] [Related]  

  • 9. Maintenance of remission in Crohn's disease: is 5'-aminosalicylic acid the answer?
    Tremaine WJ
    Gastroenterology; 1992 Aug; 103(2):694-6. PubMed ID: 1353043
    [No Abstract]   [Full Text] [Related]  

  • 10. Mesalazine as maintenance treatment in Crohn's disease.
    Vos J; Lesterhuis W
    Gastroenterology; 1994 Feb; 106(2):553-4. PubMed ID: 8299923
    [No Abstract]   [Full Text] [Related]  

  • 11. [Aminosalicylates in the treatment of chronic inflammatory bowel diseases].
    Hartmann F; Plauth M
    Internist (Berl); 1990 Nov; 31(11):702-6. PubMed ID: 2289856
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current medical therapies for Crohn's disease in Japan].
    Munakata A; Haga Y
    Nihon Geka Gakkai Zasshi; 1997 Apr; 98(4):406-11. PubMed ID: 9168493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Crohn's disease with peroral 5-aminosalicylic acid.
    Rasmussen SN; Binder V; Maier K; Bondesen S; Fischer C; Klotz U; Hansen SH; Hvidberg EF
    Gastroenterology; 1983 Dec; 85(6):1350-3. PubMed ID: 6354827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tubulointerstitial nephritis caused by mesalazine (5-ASA) agents].
    Smilde TJ; van Liebergen FJ; Koolen MI; Gerlag PG; Assmann KJ; Berden JH
    Ned Tijdschr Geneeskd; 1994 Dec; 138(51):2557-61. PubMed ID: 7830805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Aminosalicylates for prevention of recurrence in patients with Crohn's disease: time for a reappraisal?
    Sutherland LR
    J Clin Gastroenterol; 1991 Feb; 13(1):5-7. PubMed ID: 2007746
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease].
    Bayerdörffer E; Bock H
    Leber Magen Darm; 1988 Apr; 18(2):104-13. PubMed ID: 3374251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of mesalazine in Crohn's disease.
    Hanauer SB
    Scand J Gastroenterol Suppl; 1990; 172():56-9. PubMed ID: 1972296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group.
    Hanauer SB; Krawitt EL; Robinson M; Rick GG; Safdi MA
    Am J Gastroenterol; 1993 Sep; 88(9):1343-51. PubMed ID: 8362827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution?
    Sahmoud T; Mary JY; Sahmoud T
    Gut; 1997 Feb; 40(2):284-5. PubMed ID: 9071946
    [No Abstract]   [Full Text] [Related]  

  • 20. Maintenance treatment for Crohn's disease: has the time arrived?
    Goldstein F
    Am J Gastroenterol; 1992 May; 87(5):551-6. PubMed ID: 1350706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.